deltatrials
Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT05610735

Combination Therapy for Recurrent Ovarian Cancer

Combination Therapy With Liposomal Doxorubicin and Withaferin A (Ashwagandha, ASWD) in Recurrent Ovarian Cancer

Sponsor: Sham Sunder Kakar

Conditions Recurrent Ovarian Cancer
Interventions Ashwagandha Combination of ASWD and DOXIL DOXIL Withaferin A
Updated 11 times since 2022 Last updated: Mar 25, 2025 Started: Sep 25, 2024 Primary completion: Nov 30, 2026 Completion: Nov 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Recurrent Ovarian Cancer and is currently actively recruiting participants. Sham Sunder Kakar leads this study, which shows 11 recorded versions since 2024 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2022 – ~Feb 2023 · 2 months · monthly snapshot~Feb 2023 – ~Jul 2023 · 5 months · monthly snapshotNot Yet Recruiting~Jul 2023 – ~Nov 2023 · 4 months · monthly snapshotNot Yet Recruiting~Nov 2023 – ~Jan 2024 · 2 months · monthly snapshot~Jan 2024 – ~May 2024 · 4 months · monthly snapshotNot Yet Recruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotRecruiting~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshot~Jun 2025 – ~Mar 2026 · 9 months · monthly snapshotRecruiting~Mar 2026 – present · 5 months · monthly snapshotRecruiting

Change History

11 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting PHASE1/PHASE2

  2. Jun 2025 — Mar 2026 [monthly]

    Recruiting PHASE1/PHASE2

  3. Apr 2025 — Jun 2025 [monthly]

    Recruiting PHASE1/PHASE2

  4. Sep 2024 — Apr 2025 [monthly]

    Recruiting PHASE1/PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

▶ Show 6 earlier versions

  1. May 2024 — Jul 2024 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  2. Jan 2024 — May 2024 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  3. Nov 2023 — Jan 2024 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  4. Jul 2023 — Nov 2023 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  5. Feb 2023 — Jul 2023 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  6. Dec 2022 — Feb 2023 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sham Sunder Kakar
  • University of Louisville
Data source: University of Louisville

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations